Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases

Iuliia A. Polina, Daria V. Ilatovskaya, Kristine Y. DeLeon-Pennell

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Release of cell free DNA (cfDNA) from damaged or dead cells routinely occurs in normal physiology. Recently, cfDNA has emerged as an essential biomarker in cardiovascular disease (CVD) of potential prognostic and diagnostic significance. Within the last decade, significant research efforts have been devoted to uncovering the mechanisms mediating cfDNA release and its outcome-predicting ability. The current review focuses on the pathways for cfDNA release in myocardial infarction, heart failure and hypertension, and discusses implementation of cfDNA monitoring to assess the overall development of these disease states and predict future complications.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalClinica Chimica Acta
StatePublished - Apr 2020


  • Cardiovascular disease
  • Inflammation
  • MMPs
  • cfDNA

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases'. Together they form a unique fingerprint.

Cite this